Administration of thyroxine to very low-birth-weight, premature infants
To the Editor.— We question the advisability of administering thyroxine to premature infants with low thyroxine (T4) levels as reported by Chowdhry et al.1 The low T4 levels noted in this report would be expected in infants of 26 to 28 weeks of gestation. The serum thyrotropin (TSH) values were norm...
Gespeichert in:
| Veröffentlicht in: | Pediatrics (Evanston) 1984-11, Vol.74 (5), p.900-900 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 900 |
|---|---|
| container_issue | 5 |
| container_start_page | 900 |
| container_title | Pediatrics (Evanston) |
| container_volume | 74 |
| creator | Schwartz, R P Hickey, D E Rathbun, M A |
| description | To the Editor.—
We question the advisability of administering thyroxine to premature infants with low thyroxine (T4) levels as reported by Chowdhry et al.1 The low T4 levels noted in this report would be expected in infants of 26 to 28 weeks of gestation. The serum thyrotropin (TSH) values were normal as was the response to thyrotropin-releasing hormone. Hadeed et al2 noted a prevalence of T4 levels less than 6.5 µg/dL in 52% of infants of 28 to 30 weeks of gestational age, 33% of infants of 31 to 33 weeks of gestational age, and 11% of infants of 34 to 36 weeks of gestational age.2 |
| doi_str_mv | 10.1542/peds.74.5.900a |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_81336243</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>81336243</sourcerecordid><originalsourceid>FETCH-LOGICAL-c245t-de10e48dbfcab03b51ffc102afb4d2ee7cfec9a7fe8caa85925ccf2dfe69d2013</originalsourceid><addsrcrecordid>eNo9kDtPwzAYRS0EKqWwsiFlYiLBzyYZqwoKUiUWmC3H_kyNkjjYDqX_nlatmO5y7hkOQrcEF0Rw-jiAiUXJC1HUGKszNCW4rnJOS3GOphgzknOMxSW6ivELY8xFSSdoMuc1q6pyilYL07nexRRUcr7PvM3SZhf8r-shSz77gbDLWr_NGxfSJt-C-9ykh2wI0Kk0Bshcb1Wf4jW6sKqNcHPaGfp4fnpfvuTrt9XrcrHONeUi5QYIBl6ZxmrVYNYIYq0mmCrbcEMBSm1B16q0UGmlKlFTobWlxsK8NhQTNkP3R-8Q_PcIMcnORQ1tq3rwY5QVYWxOOduDxRHUwccYwMohuE6FnSRYHsrJQzlZcinkodz-cHcyj00H5h8_pWJ_clttWg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>81336243</pqid></control><display><type>article</type><title>Administration of thyroxine to very low-birth-weight, premature infants</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Schwartz, R P ; Hickey, D E ; Rathbun, M A</creator><creatorcontrib>Schwartz, R P ; Hickey, D E ; Rathbun, M A</creatorcontrib><description>To the Editor.—
We question the advisability of administering thyroxine to premature infants with low thyroxine (T4) levels as reported by Chowdhry et al.1 The low T4 levels noted in this report would be expected in infants of 26 to 28 weeks of gestation. The serum thyrotropin (TSH) values were normal as was the response to thyrotropin-releasing hormone. Hadeed et al2 noted a prevalence of T4 levels less than 6.5 µg/dL in 52% of infants of 28 to 30 weeks of gestational age, 33% of infants of 31 to 33 weeks of gestational age, and 11% of infants of 34 to 36 weeks of gestational age.2</description><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.74.5.900a</identifier><identifier>PMID: 6493887</identifier><language>eng</language><publisher>United States</publisher><subject>Humans ; Infant, Low Birth Weight ; Infant, Newborn ; Infant, Premature, Diseases - drug therapy ; Respiratory Distress Syndrome, Newborn - drug therapy ; Thyroxine - adverse effects</subject><ispartof>Pediatrics (Evanston), 1984-11, Vol.74 (5), p.900-900</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6493887$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schwartz, R P</creatorcontrib><creatorcontrib>Hickey, D E</creatorcontrib><creatorcontrib>Rathbun, M A</creatorcontrib><title>Administration of thyroxine to very low-birth-weight, premature infants</title><title>Pediatrics (Evanston)</title><addtitle>Pediatrics</addtitle><description>To the Editor.—
We question the advisability of administering thyroxine to premature infants with low thyroxine (T4) levels as reported by Chowdhry et al.1 The low T4 levels noted in this report would be expected in infants of 26 to 28 weeks of gestation. The serum thyrotropin (TSH) values were normal as was the response to thyrotropin-releasing hormone. Hadeed et al2 noted a prevalence of T4 levels less than 6.5 µg/dL in 52% of infants of 28 to 30 weeks of gestational age, 33% of infants of 31 to 33 weeks of gestational age, and 11% of infants of 34 to 36 weeks of gestational age.2</description><subject>Humans</subject><subject>Infant, Low Birth Weight</subject><subject>Infant, Newborn</subject><subject>Infant, Premature, Diseases - drug therapy</subject><subject>Respiratory Distress Syndrome, Newborn - drug therapy</subject><subject>Thyroxine - adverse effects</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kDtPwzAYRS0EKqWwsiFlYiLBzyYZqwoKUiUWmC3H_kyNkjjYDqX_nlatmO5y7hkOQrcEF0Rw-jiAiUXJC1HUGKszNCW4rnJOS3GOphgzknOMxSW6ivELY8xFSSdoMuc1q6pyilYL07nexRRUcr7PvM3SZhf8r-shSz77gbDLWr_NGxfSJt-C-9ykh2wI0Kk0Bshcb1Wf4jW6sKqNcHPaGfp4fnpfvuTrt9XrcrHONeUi5QYIBl6ZxmrVYNYIYq0mmCrbcEMBSm1B16q0UGmlKlFTobWlxsK8NhQTNkP3R-8Q_PcIMcnORQ1tq3rwY5QVYWxOOduDxRHUwccYwMohuE6FnSRYHsrJQzlZcinkodz-cHcyj00H5h8_pWJ_clttWg</recordid><startdate>198411</startdate><enddate>198411</enddate><creator>Schwartz, R P</creator><creator>Hickey, D E</creator><creator>Rathbun, M A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198411</creationdate><title>Administration of thyroxine to very low-birth-weight, premature infants</title><author>Schwartz, R P ; Hickey, D E ; Rathbun, M A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c245t-de10e48dbfcab03b51ffc102afb4d2ee7cfec9a7fe8caa85925ccf2dfe69d2013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Humans</topic><topic>Infant, Low Birth Weight</topic><topic>Infant, Newborn</topic><topic>Infant, Premature, Diseases - drug therapy</topic><topic>Respiratory Distress Syndrome, Newborn - drug therapy</topic><topic>Thyroxine - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schwartz, R P</creatorcontrib><creatorcontrib>Hickey, D E</creatorcontrib><creatorcontrib>Rathbun, M A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schwartz, R P</au><au>Hickey, D E</au><au>Rathbun, M A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Administration of thyroxine to very low-birth-weight, premature infants</atitle><jtitle>Pediatrics (Evanston)</jtitle><addtitle>Pediatrics</addtitle><date>1984-11</date><risdate>1984</risdate><volume>74</volume><issue>5</issue><spage>900</spage><epage>900</epage><pages>900-900</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><abstract>To the Editor.—
We question the advisability of administering thyroxine to premature infants with low thyroxine (T4) levels as reported by Chowdhry et al.1 The low T4 levels noted in this report would be expected in infants of 26 to 28 weeks of gestation. The serum thyrotropin (TSH) values were normal as was the response to thyrotropin-releasing hormone. Hadeed et al2 noted a prevalence of T4 levels less than 6.5 µg/dL in 52% of infants of 28 to 30 weeks of gestational age, 33% of infants of 31 to 33 weeks of gestational age, and 11% of infants of 34 to 36 weeks of gestational age.2</abstract><cop>United States</cop><pmid>6493887</pmid><doi>10.1542/peds.74.5.900a</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0031-4005 |
| ispartof | Pediatrics (Evanston), 1984-11, Vol.74 (5), p.900-900 |
| issn | 0031-4005 1098-4275 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_81336243 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Humans Infant, Low Birth Weight Infant, Newborn Infant, Premature, Diseases - drug therapy Respiratory Distress Syndrome, Newborn - drug therapy Thyroxine - adverse effects |
| title | Administration of thyroxine to very low-birth-weight, premature infants |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T01%3A11%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Administration%20of%20thyroxine%20to%20very%20low-birth-weight,%20premature%20infants&rft.jtitle=Pediatrics%20(Evanston)&rft.au=Schwartz,%20R%20P&rft.date=1984-11&rft.volume=74&rft.issue=5&rft.spage=900&rft.epage=900&rft.pages=900-900&rft.issn=0031-4005&rft.eissn=1098-4275&rft_id=info:doi/10.1542/peds.74.5.900a&rft_dat=%3Cproquest_cross%3E81336243%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=81336243&rft_id=info:pmid/6493887&rfr_iscdi=true |